The Protein Tyrosine Phosphatase Activity of Eyes Absent Contributes to Tumor Angiogenesis and Tumor Growth

Yuhua Wang1, Ram Naresh Pandey1, Stephen Riffle1

  • 1Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Insights

The Eyes Absent (EYA) protein EYA3 is crucial for DNA repair and tumor growth. Inhibiting EYA3 in host endothelial cells or tumor cells, or its phosphatase activity, hinders tumor angiogenesis and proliferation.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • DNA Damage Response

Background:

  • Cellular survival and proliferation under stress depend on DNA damage repair capacity.
  • Histone protein H2AX is central to DNA repair complex assembly, preventing cell death.
  • Eyes Absent (EYA) proteins regulate H2AX by dephosphorylating its terminal tyrosine residue.

Purpose of the Study:

  • To investigate the distinct roles of host vascular endothelial cell EYA and tumor cell EYA in tumor growth.
  • To evaluate the therapeutic potential of targeting EYA in cancer treatment.

Main Methods:

  • Genetic manipulation (gene deletion) to study EYA3 function in host endothelial and tumor cells.
  • Chemical biology approach using a specific EYA tyrosine phosphatase inhibitor.
  • Xenograft models to assess tumor growth, angiogenesis, and proliferation.

Main Results:

  • Deletion of Eya3 in host endothelial cells significantly reduced tumor angiogenesis and overall tumor growth.
  • Deletion of Eya3 in tumor cells decreased tumor cell proliferation and growth, without impacting angiogenesis.
  • A chemical inhibitor targeting EYA phosphatase activity effectively inhibited both tumor angiogenesis and tumor growth.

Conclusions:

  • EYA3 plays a dual role in tumor progression, affecting both tumor cell-autonomous growth and tumor angiogenesis.
  • Targeting EYA phosphatase activity offers a promising therapeutic strategy for simultaneously inhibiting tumor vasculature and tumor cells.
  • This dual-targeting approach may overcome resistance mechanisms associated with conventional anti-angiogenic therapies.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.9K